Summary : The expert panel of India’s central drug authority on Monday recommended granting restricted Emergency Use Authorisation (EUA) to Biological E’s…
Tag:
SII
-
-
Covid DrugsIndia
Health ministry notifies provisions under Drugs Rules to manufacture, stock, sale new drugs in wake of Covid-19
by adminby adminSummary – The outbreak of Covid-19 pandemic has made it necessary to regulate the manufacture, stock, sale or distribution of new drug…
-
AgrochemicalsIndia
Serum Institute CEO Hails WHO’s Approval of Covovax for Emergency Use
by adminby adminSynopsis- India-made Covovax on Friday became the ninth Covid-19 vaccine to receive WHO’s emergency use listing approval, with manufacturer Serum Institute of…
-
Pharma Science & Research
Novavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 Vaccine in Indonesia
by adminby adminNovavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and Serum Institute of…
-
Active Pharmaceutical Ingredients (API)COVAXIndia
Serum Institute looks to supply 25 million doses to Covax till December
by adminby adminPune-based Serum Institute of India (SII) is expected to supply 25 million doses to the Covax facility till December, as it looks…